These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 25475416)
1. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study. Trusell H; Sundell KA BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416 [TBL] [Abstract][Full Text] [Related]
2. Refill Adherence in Relation to Substitution and the Use of Multiple Medications: A Nationwide Population Based Study on New ACE-Inhibitor Users. Bjerkeli PJ; Jönsson AK; Lesén E; Mårdby AC; Sundell KA PLoS One; 2016; 11(5):e0155465. PubMed ID: 27192203 [TBL] [Abstract][Full Text] [Related]
3. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland. Helin-Salmivaara A; Korhonen MJ; Alanen T; Huupponen R J Clin Pharm Ther; 2012 Feb; 37(1):58-64. PubMed ID: 21410736 [TBL] [Abstract][Full Text] [Related]
4. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom. Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487 [TBL] [Abstract][Full Text] [Related]
5. A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project. Lesén E; Sandström TZ; Carlsten A; Jönsson AK; Mårdby AC; Sundell KA Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1073-9. PubMed ID: 21853505 [TBL] [Abstract][Full Text] [Related]
6. Generic and therapeutic statin switches and disruptions in therapy. Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292 [TBL] [Abstract][Full Text] [Related]
7. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study. Degli Esposti L; Sangiorgi D; Buda S; Degli Esposti E; Scaglione F BMJ Open; 2016 Nov; 6(11):e012003. PubMed ID: 27807083 [TBL] [Abstract][Full Text] [Related]
8. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry. O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864 [TBL] [Abstract][Full Text] [Related]
9. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005 [TBL] [Abstract][Full Text] [Related]
10. Is the level of patient co-payment for medicines associated with refill adherence in Sweden? Lesén E; Andersson Sundell K; Carlsten A; Mårdby AC; Jönsson AK Eur J Public Health; 2014 Feb; 24(1):85-90. PubMed ID: 23748594 [TBL] [Abstract][Full Text] [Related]
11. Lowering copayments: impact of simvastatin patent expiration on patient adherence. Sedjo RL; Cox ER Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498 [TBL] [Abstract][Full Text] [Related]
13. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting. Rathe JØ Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397 [TBL] [Abstract][Full Text] [Related]
14. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689 [TBL] [Abstract][Full Text] [Related]
15. Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study. Settergren J; Eiermann B; Mannheimer B PLoS One; 2013; 8(8):e69545. PubMed ID: 23940522 [TBL] [Abstract][Full Text] [Related]
16. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006. Li P; Schwartz JS; Doshi JA J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27836822 [TBL] [Abstract][Full Text] [Related]
17. Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia. Casula M; Scotti L; Tragni E; Merlino L; Corrao G; Catapano AL Atherosclerosis; 2016 Nov; 254():172-178. PubMed ID: 27750108 [TBL] [Abstract][Full Text] [Related]
18. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence. Wong MC; Wang HH; Liu KS Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540 [No Abstract] [Full Text] [Related]
19. Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications. Kwon HY; Godman B BMC Health Serv Res; 2016 Apr; 16():130. PubMed ID: 27080530 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]